Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
Saved in:
| Title: | Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. |
|---|---|
| Authors: | Tuteja S; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Salloum RG; University of Florida College of Medicine, Gainesville, Florida, USA., Elchynski AL; University of Florida College of Pharmacy, Gainesville, Florida, USA., Smith DM; MedStar Health, Georgetown University Medical Center, Washington, DC, USA., Rowe E; Indiana University School of Medicine, Indianapolis, Indiana, USA., Blake KV; Nemours Children's Health, Jacksonville, Florida, USA., Limdi NA; University of Alabama School of Medicine, Birmingham, Alabama, USA., Aquilante CL; University of Colorado School of Medicine and Pharmacy, Aurora, Colorado, USA., Bates J; Durham VA Healthcare System, Durham, North Carolina, USA., Beitelshees AL; University of Maryland School of Medicine, Baltimore, Maryland, USA., Cipriani A; University of North Carolina Medical Center, Chapel Hill, North Carolina, USA., Duong BQ; Nemours Children's Health, Wilmington, Delaware, USA., Empey PE; University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA., Formea CM; Intermountain Healthcare, Salt Lake City, Utah, USA., Hicks JK; Moffitt Cancer Center, Tampa, Florida, USA., Mroz P; University of Minnesota Medical School, Minneapolis, Minnesota, USA., Oslin D; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA., Pasternak AL; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA., Petry N; North Dakota State University/Sanford Health, Fargo, North Dakota, USA., Ramsey LB; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Schlichte A; Fairview Pharmacy Services, Minneapolis, Minnesota, USA., Swain SM; MedStar Health, Georgetown University Medical Center, Washington, DC, USA., Ward KM; University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA., Wiisanen K; University of Florida College of Pharmacy, Gainesville, Florida, USA., Skaar TC; Indiana University School of Medicine, Indianapolis, Indiana, USA., Van Driest SL; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Cavallari LH; University of Florida College of Pharmacy, Gainesville, Florida, USA., Bishop JR; University of Minnesota Medical School, Minneapolis, Minnesota, USA.; University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA. |
| Corporate Authors: | IGNITE Pharmacogenetics Working Group |
| Source: | Clinical and translational science [Clin Transl Sci] 2022 Feb; Vol. 15 (2), pp. 371-383. Date of Electronic Publication: 2021 Sep 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.13154 |
